<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Medical Microbiology and Infectious Diseases</title>
<title_fa>Journal of Medical Microbiology and Infectious Diseases</title_fa>
<short_title>JoMMID</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jommid.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2345-5349</journal_id_issn>
<journal_id_issn_online>2345-5330</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/JoMMID</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>7</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>In vitro Delivery of HIV-1 Nef Antigen by Histidine-rich nona-arginine and Latarcin 1 peptide</title>
	<subject_fa>Other</subject_fa>
	<subject>Other</subject>
	<content_type_fa>Original article</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Introduction: &lt;/strong&gt;The Nef accessory protein is an attractive antigenic candidate in the development of HIV-1 DNA- or protein-based vaccines. The most crucial disadvantage of DNA and protein-based vaccines is their low immunogenicity, which can be improved by cell-penetrating peptides (CPPs) as effective carrier molecules. &lt;strong&gt;Methods: &lt;/strong&gt;In this study, the HIV-1 Nef protein was generated in the &lt;em&gt;Escherichia coli &lt;/em&gt;expression system for &lt;em&gt;in vitro&lt;/em&gt; delivery using a novel CPP, Latarcin 1 peptide, in a non-covalent manner. Also, the Histidine-rich nona-arginine peptide was utilized to transfer the HIV-1 Nef gene. The size, morphology, and zeta potential of the complexes were evaluated by scanning electron microscopy (SEM) and Zetasizer. The efficiency of cell transfection was studied using a fluorescence microscopy and flow cytometry for the DNA/CPP complexes and western blot analysis for the protein/CPP complexes. &lt;strong&gt;Results: &lt;/strong&gt;The Nef protein generated in the BL21 strain migrated as a dominant band of ~30 kDa in SDS-PAGE. The SEM data confirmed the formation of stable complexes with a size below 200 nm. MTT assay demonstrated that the complexes did not represent any considerable cytotoxic effect compared to untreated HEK-293T cells. The results of fluorescence microscopy, flow cytometry, and western blotting revealed that the Nef DNA and protein constructs could be significantly transfected into HEK-293T cell line using these CPPs. &lt;strong&gt;Conclusion: &lt;/strong&gt;These data suggest that the Histidine-rich nona-arginine peptide and Latarcin 1 peptide as CPPs can be considered as a promising approach in the development of the HIV-1 vaccine for gene or protein delivery.&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Therapeutic vaccine, HIV-1 Nef, Cell-penetrating peptides, Transfection</keyword>
	<start_page>107</start_page>
	<end_page>115</end_page>
	<web_url>http://jommid.pasteur.ac.ir/browse.php?a_code=A-10-123-4&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Namazi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0003-4611-855X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Azam</first_name>
	<middle_name></middle_name>
	<last_name>Bolhassani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>azam.bolhassani@yahoo.com</email>
	<code></code>
	<orcid>0000000173637406</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Mehdi</first_name>
	<middle_name></middle_name>
	<last_name>Sadat</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0001-7739-179X</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shiva</first_name>
	<middle_name></middle_name>
	<last_name>Irani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid>0000-0002-4202-9931</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
